Illuminating Immunodeficiency 39: The Role of Genetic Testing in Diagnosis and Management
Unravel Immunodeficiency 39 with genetic testing. Gain insights into early diagnosis, personalized treatment plans, and informed family planning strategies.
Brandon Colby, MD
MD · MBA
Physician specializing in genetic analysis and personalized preventive medicine, and author of Outsmart Your Genes.
About Brandon
Brandon Colby is a physician-expert in the fields of genetic analysis and Personalized Preventive Medicine. He holds an MD from the Mount Sinai School of Medicine, an MBA from Stanford University's Graduate School of Business, and a degree in Genetics from the University of Michigan.
Dr. Colby is the author of the book Outsmart Your Genes and has developed numerous technologies that improve the analysis, interpretation, and actionability of genome sequencing data. He is an Affiliate Specialist of the American College of Medical Genetics and Genomics (ACMG), an Associate of the American College of Preventive Medicine (ACPM), and a member of the National Society of Genetic Counselors (NSGC).
Education
- BA in Genetics with Honors, University of Michigan · 2000
- MD, Mount Sinai School of Medicine · 2004
- MBA, Stanford University Graduate School of Business · 2007
Affiliations & Memberships
- Affiliate Specialist, American College of Medical Genetics and Genomics (ACMG)
- Associate, American College of Preventive Medicine (ACPM)
- Member, National Society of Genetic Counselors (NSGC)
Articles by Brandon Colby, MD are reviewed for accuracy by Sequencing's medical and scientific team. This page is for informational purposes and does not constitute medical advice.
Articles by Brandon
Illuminating Immunodeficiency: Genetic Testing and Common Variable Immunodeficiency, 12
Genetic testing unveils the IKZF1 gene's role in CVID12, aiding early diagnosis, personalized treatments, and family risk assessment for better health outcomes.
Illuminating Infantile Liver Failure Syndrome 2: The Role of Genetic Testing in Unraveling Mysteries
Explore the impact of genetic testing in diagnosing Infantile Liver Failure Syndrome 2. Learn about NBAS gene mutations, early diagnosis, and personalized treatments.
Illuminating Intellectual Disability, Autosomal Dominant 33: The Role of Genetic Testing
Explore the impact of genetic testing on diagnosing Intellectual Disability, Autosomal Dominant 33, highlighting early diagnosis, genetic counseling, and therapeutic potential.
Illuminating Insights: Genetic Testing for Intellectual Disability, Autosomal Dominant 34
Explore how genetic testing, particularly whole exome sequencing, aids in diagnosing Intellectual Disability, Autosomal Dominant 34 by identifying critical mutations.
Illuminating Insights: Genetic Testing for Intellectual Disability, Autosomal Dominant 38
Explore the impact of genetic testing in diagnosing Intellectual Disability, Autosomal Dominant 38, enhancing early diagnosis, personalized care, and family planning.
Illuminating Intellectual Disability, Autosomal Dominant 39: The Role of Genetic Testing
Explore the impact of genetic testing in diagnosing ID-AD39, a condition linked to SETBP1 mutations, aiding early intervention and personalized treatment plans.
Illuminating Intellectual Disability, Autosomal Dominant 40: The Role of Genetic Testing in Diagnosis and Management
Explore how advanced genetic testing, like whole exome sequencing, aids in diagnosing and managing Intellectual Disability, Autosomal Dominant 40.